This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. The contract, valued at $462,456.28, is for the delivery of radioactive isotopes to support nuclear medicine procedures, diagnostic imaging, and cancer treatment across the VA's nationwide network of medical facilities.
Jubilant Radiopharma is a subsidiary of Jubilant Life Sciences Limited and specializes in manufacturing, distributing, and supplying radiopharmaceuticals and nuclear medicine products. The company holds multiple Indefinite Delivery Vehicles (IDVs) with the VA, including Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs), with potential values ranging from $420,000 to $39.8 million. These IDVs allow the VA to efficiently procure radiopharmaceuticals and related services across its Veterans Integrated Service Networks (VISNs). The contract is not set aside and has a performance period ending on February 28, 2025.